COSMOS Pharmaceutical Corporation

3349.T
Pharmaceutical Retailers
2026/01/16 Updated
Market Cap: $3.5B (¥547.0B)
Stock Price: $43.55 (¥6,901)
Exchange Rate: 1 USD = ¥158.48

Notice of Organizational Changes and Personnel Transfers

Effective February 1, 2026, the Legal Department and Hotel Department will be newly established, and the Product Development Department will be integrated into the Product Department. Personnel transfers for directors and department heads will be implemented.

Importance:
Page Updated: January 13, 2026
IR Disclosure Date: January 13, 2026

Key Figures

  • Establishment of Legal Department: effective February 1, 2026
  • Establishment of Hotel Department: effective February 1, 2026
  • Abolition of Product Development Department: Product Development Section integrated into Product Department

AI要約

Overview of Organizational Changes

Cosmos Pharmaceutical Co., Ltd. will establish a Legal Department and a Hotel Department as of February 1, 2026, to strengthen its internal structure. Meanwhile, the Product Development Department will be abolished and integrated into the Product Department as the Product Development Section. This aims to enhance legal functions and expand new business domains.

Details of Personnel Transfers

Personnel transfers for directors and department heads will be conducted. Director Ta Shibata will assume the role of Legal Department Head, changing from concurrently serving as Head of Corporate Planning. Director Fumitaka Uno will be reassigned as Head of Finance and Accounting Department, previously serving as Head of Product Department. Additionally, multiple position changes for Corporate Planning Department Head, Product Department Head, Hotel Department Head, Store Development Department Head, and others will be implemented to strengthen organizational functions.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.